#H.I.G. Capital #London #United Kingdom #ITH Group Limited #aseptic compounding

H.I.G. Capital Completes the Acquisition of ITH Group Limited

On June 9, 2025, H.I.G. Capital, a leading global alternative investment firm with $70 billion in capital under management, announced the completion of its acquisition of ITH Group Limited, a premier provider of aseptic compounding services based in the UK. This strategic acquisition marks a significant expansion of H.I.G.'s portfolio in the pharmaceutical services sector, particularly focusing on tailored injectable medication for patients with specific medical needs.

ITH Group has carved out a niche in the market by developing custom injectable medications, especially for patients who require treatments that existing alternatives cannot meet. The company is recognized as a market leader in chemotherapy, total parenteral nutrition, and centralized intravenous additive services, supplying high-quality, custom medications for both adults and newborns. ITH also operates a leading online pharmacy that provides essential licensed medications to private patients and the NHS.

Since its inception in 2008, ITH Group has consistently expanded its operations by investing in its personnel and enhancing service delivery for patients. With the backing of H.I.G. Capital, ITH intends to pursue organic growth vigorously while also focusing on new initiatives aimed at boosting production capacity. The current management team, including CEO Adam Bloom and COO Karen Hamling, will remain in their positions, ensuring continuity and leadership stability as the company embarks on this new chapter.

Adam Bloom, CEO of ITH Group, expressed enthusiasm about H.I.G's investment, noting, "I am thrilled to welcome H.I.G. as a key investor in ITH Group. Since our foundation, we've focused on growth by investing in our team and improving the services we offer to patients. Today, we proudly stand as one of the leading providers of aseptic compounding services in the UK, supporting both the NHS and private healthcare sectors. Looking ahead, we are committed to expanding our service offerings and enhancing our expertise in delivering critical compounded medications."

John Harper, Managing Director of H.I.G. Europe’s Lower Middle Market LBO team, also commented, "We are excited to support Adam, Karen, and their team in further developing ITH's success. The company's reliable provision of compounded medications to NHS and private clients is vital in an inherently underserved market. H.I.G.'s experience in supporting capacity expansion for portfolio companies synergizes well with ITH's operations, opening up an exciting new chapter for the company."

Furthermore, Gordon Cameron, Non-Executive Chairman of ITH, remarked, "Adam and Karen have built an impressive business that delivers essential services to the healthcare sector in the UK. The company has established a reputation for being exceptionally reliable in the market, owing to its unwavering commitment to quality and customer service. I look forward to being part of the company under H.I.G.'s investment as we contribute to the next phase of its growth."

Overview of ITH Group

Founded in 2008, ITH Group is specialized in providing aseptic compounding services, targeting both NHS and private clients with a strong emphasis on chemotherapy, total parenteral nutrition, and centralized intravenous additives. The firm is headquartered in London, UK, and has evolved into one of the key players in the market for compounded pharmaceutical services, demonstrating consistent growth and innovation.

About H.I.G. Capital

H.I.G. Capital has made a name as a prominent global alternative investment firm, managing $70 billion in total capital. With its headquarters in Miami and regional offices in major cities such as Atlanta, Boston, Chicago, Los Angeles, New York, San Francisco, and Stamford, as well as international offices in key locations across Europe and Latin America, H.I.G. focuses on providing debt and equity capital to mid-market companies. The firm employs a flexible, operationally-focused, and value-added approach to its investments, with a commitment to fostering the growth of businesses across various sectors. Since its founding in 1993, H.I.G. has invested in over 400 companies worldwide.

For further details on ITH Group and H.I.G. Capital, visit their official websites.